Behavioral Activation and HIV Risk Reduction for Men Who Have Sex With Men With Crystal Meth Abuse
Status unconfirmed · Phase 1
Conditions studied: Crystal Methamphetamine Abuse, Crystal Methamphetamine Dependence
In brief
The purpose of this study is to research a new behavioral treatment to reduce sexual risk-taking in men who have sex with men (MSM) who abuse crystal methamphetamine (crystal meth), and are at risk for HIV acquisition. This study proposes using a treatment based on our original pilot study that incorporates risk reduction and behavioral activation therapy. In order to help learn what types of treatment programs best help individuals who abuse crystal meth and engage in sexual risk-taking, we will compare our treatment to a control group. The treatment group will receive therapy incorporating behavioral risk reduction counseling with behavioral activation therapy to treat depression, helping individuals reengage in their life. The control group will receive the risk reduction counseling without the behavioral activation therapy. The current study hopes to explore the efficacy of this previous developed treatment in a two-arm pilot randomized controlled trial.
Key facts
- Study ID
- NCT01255280
- Run by
- Massachusetts General Hospital
- People needed
- 50
- Starts
- 2011-01-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2012-06-01
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Age: 18 years or older
- Self-reports as a man who has sex with men
- HIV-uninfected and verifies serostatus at baseline (HIV antibody testing and positive tests will be confirmed by Western Blots; see Human Subjects for operational aspects)
- Meets DSM-IV diagnostic criteria for crystal meth abuse/dependence
- Self reported unprotected anal intercourse-receptive or insertive-with a non-monogamous male sexual partner, while concurrently using crystal meth (use of meth must be a few hours prior to, or during, sex) in the prior three months
You may not qualify if…
- Unable to provide informed consent due to severe mental or physical illness, or substance intoxication at the time of interview
- Has lived in the greater Boston area for three months or less (as a means to enhance participant retention)
- Discovery of active suicidal ideation at the time of interview (these patients will be referred immediately for treatment, but may join the study when this is resolved)
Where it is running
- Fenway Community Health — Boston, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.